Trial Profile
A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide Tablets 100 mg/25 mg Under Fed Conditions.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Apr 2010
Price :
$35
*
At a glance
- Drugs Losartan/hydrochlorothiazide (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- 15 Apr 2010 New trial record